Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
Is a |
Product containing caffeine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
Is a |
Product containing dihydrocodeine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
Is a |
kombinationspræparat med acetylsalicylsyre |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydrocodeinbitartrat |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Aspirin (substance) |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydrocodeine (substance) |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator (substance) |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opioid receptor agonist |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phosphodiesterase inhibitor |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydrocodeine tartrate |
false |
Inferred relationship |
Some |
|
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
Is a |
Product containing aspirin (medicinal product) |
false |
Inferred relationship |
Some |
|
|